The Alper lab focuses on engineering biology to produce organic molecules of interest such as biofuels, commodity and specialty chemicals, and protein pharmaceuticals. To accomplish these tasks, traditional pathway engineering approaches are merged with novel synthetic biology tools, protein engineering strategies, systems biology paradigms and applied genetic engineering capabilities. The group utilizes a variety of host systems including microbial (eg. Escherichia coli), fungal (eg. the yeasts Saccharomyces cerevisiae and Yarrowia lipolytica), and mammalian cells (eg. Chinese Hamster Ovary (CHO) cells and Human HEK293) to produce a diverse array of products. In each case, the goal is to “rewire” cellular systems into industrially-relevant biochemical factories.
News Archives
- October 2022
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- March 2017
- October 2015
- September 2015
- August 2015
- July 2015
- October 2014
- September 2014
- July 2014
- May 2014
- August 2013
- July 2013
- June 2013
- April 2013
- January 2013
- December 2012
- November 2012
- August 2012
- July 2012